Concourse Financial Group Securities’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2356 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4009 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 4001 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4040 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 4053 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 3992 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3958 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3921 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3834 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3799 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 3578 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 3633 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 3580 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 3710 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3662 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3561 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3487 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 3414 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3256 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3160 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3194 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3136 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2850 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3180 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 3160 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 3042 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2625 |
|